Cite
MLA Citation
Mathilde Tardieu et al.. “Cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis.” Pediatric blood & cancer, vol. 68, no. 9, 2021, p. n/a. http://access.bl.uk/ark:/81055/vdc_100135172538.0x00001f